MedPath

Hydrochlorothiazide

HYDROCHLOROTHIAZIDE TABLETS USP

Approved
Approval ID

fe6200cc-3182-473c-a90a-a8caa2fb2818

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 16, 2010

Manufacturers
FDA

Contract Pharmacy Services-PA

DUNS: 945429777

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydrochlorothiazide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67046-276
Application NumberANDA040702
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydrochlorothiazide
Product Specifications
Route of AdministrationORAL
Effective DateApril 8, 2009
FDA Product Classification

INGREDIENTS (1)

HydrochlorothiazideActive
Quantity: 50 mg in 1 1
Code: 0J48LPH2TH
Classification: ACTIB

Hydrochlorothiazide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67046-275
Application NumberANDA040702
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydrochlorothiazide
Product Specifications
Route of AdministrationORAL
Effective DateApril 8, 2009
FDA Product Classification

INGREDIENTS (1)

HydrochlorothiazideActive
Quantity: 25 mg in 1 1
Code: 0J48LPH2TH
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hydrochlorothiazide - FDA Drug Approval Details